MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, TARS has $534,561K in assets. $199,479K in debts.

Balance Sheets Overview

Current Ratio
428.62%
Quick Ratio
425.35%
Debt to Asset Ratio
37.32%
Assets Breakdown
    • Marketable securities
    • Cash and cash equivalents
    • Accounts receivable, net
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accounts payable and other accru...
    • Others

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Balance Sheets
2025-09-30
2025-06-30
Cash and cash equivalents
112,724 96,648
Marketable securities
289,113 284,495
Accounts receivable, net
72,620 58,334
Inventory
3,836 3,873
Other receivables
1,716 1,906
Prepaid expenses
21,695 29,173
Total current assets
501,704 474,429
Restricted cash, non-current
2,563 2,563
Inventory, non-current
2,532 2,532
Property and equipment, net
5,746 3,182
Intangible assets, net
7,606 7,846
Operating lease right-of-use assets
10,233 229
Long-term investments
3,000 3,000
Other assets
1,177 1,213
Total assets
534,561 494,994
Accounts payable and other accrued liabilities
103,498 78,641
Accrued payroll and benefits
13,552 11,612
Total current liabilities
117,050 90,253
Long-term debt, net
72,281 72,129
Other long-term liabilities
10,148 -
Total liabilities
199,479 162,382
Common stock, 0.0001 par value 200,000,000 shares authorized 42,447,882 shares issued and outstanding at september30, 2025 (unaudited) 38,349,826 shares issued and outstanding at december31, 2024
6 6
Additional paid-in capital
753,042 738,237
Accumulated other comprehensive income (loss)
289 39
Accumulated deficit
-418,255 -405,670
Total stockholders equity
335,082 332,612
Total liabilities and stockholders equity
534,561 494,994
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Prepaid expenses$21,695K Other receivables$1,716K Inventory$3,836K Accounts receivable, net$72,620K Marketable securities$289,113K Cash and cashequivalents$112,724K Other assets$1,177K Long-term investments$3,000K Operating leaseright-of-use assets$10,233K Intangible assets, net$7,606K Property and equipment,net$5,746K Inventory, non-current$2,532K Restricted cash,non-current$2,563K Total current assets$501,704K Total assets$534,561K Total liabilities andstockholders equity$534,561K Total stockholdersequity$335,082K Total liabilities$199,479K Accumulated deficit-$418,255K Accumulated othercomprehensive income (loss)$289K Additional paid-in capital$753,042K Other long-termliabilities$10,148K Long-term debt, net$72,281K Total currentliabilities$117,050K Common stock, 0.0001par value...$6K Accrued payroll andbenefits$13,552K Accounts payable andother accrued...$103,498K

Tarsus Pharmaceuticals, Inc. (TARS)

Tarsus Pharmaceuticals, Inc. (TARS)